We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,953.00
Bid: 6,953.00
Ask: 6,955.00
Change: -57.00 (-0.81%)
Spread: 2.00 (0.03%)
Open: 7,001.00
High: 7,172.00
Low: 6,943.00
Yest. Close: 7,010.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 5-AstraZeneca hitches ride with Russia's Sputnik in vaccine race

* Trial to start by the end of the year - Russia's RDIF* Boost for Russian vaccine, which has been criticised in West* Once COVID-19 vaccine frontrunner, AstraZeneca has slipped back (Updates with Russian defence ministry comment, edits)By Andrew ...

11 Dec 20 09:27

AstraZeneca to work on vaccine combinations with Sputnik developer

Dec 11 (Reuters) - Britain's AstraZeneca on Friday said that it will begin work with Russia's Gamaleya Institute to understand whether their two COVID-19 vaccine candidates can be successfully combined.The Gamaleya Institute is the developer of Ru...

11 Dec 20 09:12

UPDATE 1-Emergency vaccine approval not legal option in Switzerland

(Adds detail, background.)By Silke KoltrowitzZURICH, Dec 11 (Reuters) - The emergency approval process being used by some countries to speed up the roll-out of COVID-19 vaccines is not a legal option in Switzerland, its medicines agency said on Fr...

11 Dec 20 07:34

UPDATE 3-Sanofi and GSK delay COVID-19 vaccine, marking setback to global fight

* Phase I/II results show low immune response in older adults* New study expected next year using improved antigen formulation* Eyes regulatory submission in the second half of 2021By Matthias BlamontPARIS, Dec 11 (Reuters) - Sanofi and GlaxoSmith...

11 Dec 20 06:26

UPDATE 4-Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight

* Phase I/II results show low immune response in older adults* Setback to global efforts to develop multiple vaccines* New study expected next year using improved formulation* Hopes for regulatory submission in second half of 2021By Matthias Blamont...

11 Dec 20 06:26

UPDATE 5-Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight

* Phase I/II results show low immune response in older adults* Setback to global efforts to develop multiple vaccines* New study expected next year using improved formulation* Sanofi hope for regulatory submission in second half of 2021 (Adds EU n...

11 Dec 20 06:26

UK has vaccinated tens of thousands against COVID-19 - minister

LONDON, Dec 10 (Reuters) - Tens of thousands of people in Britain have received the Pfizer-BioNTech COVID-19 vaccine after a mass vaccination programme began earlier this week, health minister Matt Hancock said on Thursday."As of today, we are vac...

10 Dec 20 17:11

Cyber attacks seen on coronavirus vaccine infrastructure-U.S. Senator Peters

WASHINGTON, Dec 10 (Reuters) - Cyber attacks have been waged against COVID-19 vaccine distribution infrastructure, including a cold-chain storage company, U.S. Senator Gary Peters said during a congressional hearing on Thursday."IBM recently relea...

10 Dec 20 15:43

UPDATE 1-Data from Pfizer/BioNTeh, Moderna for COVID-19 vaccines 'very robust'-EMA

(adds details on UK allergy cases, AstraZeneca, Johnson & Johnson)BRUSSELS, Dec 10 (Reuters) - The data submitted to the European Medicines Agency (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 vaccine candidates is "very robust", its ex...

10 Dec 20 14:37

REFILE-UPDATE 1-Data from Pfizer/BioNTech, Moderna for COVID-19 vaccines 'very robust'-EMA

(refiles with correct spelling of BioNTech in headline)BRUSSELS, Dec 10 (Reuters) - The data submitted to the European Medicines Agency (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 vaccine candidates is "very robust", its executive dire...

10 Dec 20 14:37

England to make support payment available through test and trace app

LONDON, Dec 10 (Reuters) - England's COVID test and trace system is making a 500 pound ($665) support payment for people told to isolate available through its app, it said on Thursday as it outlined a plan for the next phase of the service.The su...

10 Dec 20 13:25

Africa disease control head calls on rich nations to share excess COVID-19 shots

By Omar MohammedNAIROBI, Dec 10 (Reuters) - Countries that have ordered more COVID-19 vaccines than they need should consider distributing excess doses to Africa, the head of the continent's disease control body said on Thursday.As African countri...

10 Dec 20 13:17

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

10 Dec 20 10:16

Oxford's Hill says its vaccine won't be available in U.S. until mid-2021 if FDA waits for trial end

Dec 9 (Reuters) - Jenner Institute Director Adrian Hill, who oversees the Oxford-AstraZeneca COVID-19 vaccine research and development, told NBC News that if the U.S. Food and Drug Administration waits for the end of their vaccine trial, the vacc...

9 Dec 20 23:08

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

9 Dec 20 16:08

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.